We ensure your FDA reports include testing that conforms to performance standards required by Title 21 of the United States Code, and cGMP standards described in Title 21 of the Codified Federal Rules.

Having served numerous clients, from Fortune 500 companies to startups, seeking approval for ethical pharmaceuticals, combination products, and class II & III medical devices, Dr. Ristow is highly experienced in ensuring your submission complies with USP, EP, and ICH performance standards and meets regulatory expectations.


Harvard Business School, Executive Education Program, October 2022.

J.D., Mitchell Hamline School of Law, May 2014.

Ph.D., SDSU, Organic Photochemistry, August 2008


Dr. Ristow serves as a graduate student mentor to the University of Saint Thomas School of Law, and founded and supports the Brent Ristow Scholarship in Chemistry at the University of Wisconsin, River Falls to honor his late mother.